Skip to content

Pericapsular Nerve Block in Proximal Femoral Fractures

Effect of Systemic Analgesia and Systemic Analgesia Associated With Pericapsular Nerve Block in Proximal Femoral Fractures

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05840458
Enrollment
21
Registered
2023-05-03
Start date
2023-04-01
Completion date
2024-12-31
Last updated
2024-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoral Fracture

Brief summary

Proximal femoral fractures commonly occur above 50 years and regional anesthesia could be a complement in the perioperative treatment of the patients. The use of pericapsular nerve group block (PENG Block) has been proposed to reduce pain. However, no studies have explored the efficient of the systemic analgesia associated with PENG Block in functional limitation in the preoperative period. In this sense, the main goal of this study is to evaluate the effectiveness of systemic analgesia associated with PENG Block in patients with proximal femoral fractures in the period preceding the surgical procedure.

Detailed description

Focus on functional capacity will be measured by the Activity Measure for Post-Acute Care (AM-PAC) short version of the 6 Clicks, pain intensity will be assessed using the numerical rating scale, and opioid consumption. This study will include 21 patients admitted to the Emergency Room with proximal femoral fractures.

Interventions

PROCEDUREPENG Block

Patient will be placed in the supine position and the ultrasound probe will be placed in the transverse plane over the anterior inferior iliac spine (AIIS) and aligned with the pubic ramus by rotating the probe counterclockwise by approximately 45 degrees. A 22-gauge, 100 mm needle will be inserted using the plane approach from lateral to medial, between the psoas tendon anteriorly and the pubic ramus posteriorly. Following a negative aspiration, 20 mL of 0.375% ropivacaine will be injected. The needle position will be confirmed by visualizing the separation of layers with the dispersion of the injected volume.

Sponsors

Hospital Sirio-Libanes
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 105 Years
Healthy volunteers
No

Inclusion criteria

* patients with unilateral proximal femoral fractures admitted to the emergency room of the Hospital Sírio-Libanes, * aged 18-105 years * with the American Society of Anesthesiology (ASA) physical status I, II, or III.

Exclusion criteria

* allergy to metamizole and/or ropivacaine * history of mental disorders * presence of chronic pain as assessed using the Douleur Neuropathique 4 (DN4) questionnaire

Design outcomes

Primary

MeasureTime frameDescription
Functional impairmentBefore the interventionThe Short-form of Activity Measure for Post-Acute Care (AM-PAC- 6 clicks) is a measure of basic patient mobility will be used. Higher scores mean better outcomes. Minimum 6 points, maximum 26 points.

Secondary

MeasureTime frameDescription
Pain levelsBefore performing the PENG blockThe Numeric Rating Scale will be used to evaluate pain levels. Higher scores mean worst. outcomes. Minimum 0 point, maximum 10 points.
Opioid consumption24 hours after performing the PENG BlockThe total opioid consumption will be evaluated 24 hours after performing the PENG Block

Countries

Brazil

Contacts

Primary ContactPedro P Kimachi, MD
ppkimachi@yahoo.com.br+5511991752029

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026